Abingdon Health confident moving into 2023
Sharecast
Published Dec 19, 2022 12:25
Updated Dec 19, 2022 14:12
Abingdon Health confident moving into 2023
Sharecast - The AIM-traded firm, which was holding its annual general meeting, said recently in its preliminary results that its strategic focus was now on contract development and manufacturing (CDMO) services.
Chief executive officer Chris Yates told shareholders on Monday that it was focussing on such services, given the expected growth in demand it expected to see within the lateral flow market, particularly in non-Covid-19 sectors such as human health, animal health, plant pathogen and environmental testing.
“Our outlook going into 2023 is unchanged, and we remain confident that our contract services customer base and current growing pipeline mean we are well positioned to grow our business,” Yates said.
“We are also reassured by our cash levels of £4.4m as at 19 December, in line with the cash position as at the end of October, and expect to have about £4.3m cash at the end of December.
“The board remains confident that we have sufficient cash resources to fund progress beyond the next 12 months, with our priority being to move the company to a positive cash flow position.”
At 1225 GMT, shares in Abingdon Health were up 10.67% at 4.15p.
Reporting by Josh White for Sharecast.com.
Read more on Sharecast.com
Get The App
Written By: Sharecast
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.